Bavarian Nordic gets new order for 1.5 million monkeypox vaccine doses

After two recent order rounds the past week, and two financial upgrades as a result, the biotech firm has announced a new order for its vaccine against monkeypox from an undisclosed European country.

Photo: Sven Hoppe/AP/Ritzau Scanpix

On Tuesday, Bavarian Nordic announced yet another order for its vaccine, approved in the monkeypox indication in the US and Canada, making it the world’s only vaccine for the infectious disease.

In a press release, the Danish vaccine maker reports it will supply 1.5 million doses to an undisclosed country in Europe, where the vaccine known as Imvanex is officially only market authorized for smallpox at present.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs